EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Kyowa Kirin Co's enterprise value is 円1,021,393 Mil.
Kyowa Kirin Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was 円91,477 Mil. Therefore, Kyowa Kirin Co's EV-to-EBITDA for today is 11.17.
The historical rank and industry rank for Kyowa Kirin Co's EV-to-EBITDA or its related term are showing as below:
TSE:4151'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.43 Med: 14.99 Max: 26.86
Current: 11.17
During the past 13 years, the highest EV-to-EBITDA of Kyowa Kirin Co was 26.86. The lowest was 7.43. And the median was 14.99.
TSE:4151's EV-to-EBITDA is ranked better than 61.5% of 709
companies
in the Drug Manufacturers industry
Industry Median: 14.88
vs TSE:4151: 11.17
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Kyowa Kirin Co EV-to-EBITDA Historical Data
The historical data trend for Kyowa Kirin Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kyowa Kirin Co's EV-to-EBITDA
For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kyowa Kirin Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Kyowa Kirin Co's EV-to-EBITDA falls into.
Kyowa Kirin Co EV-to-EBITDA Calculation
Kyowa Kirin Co's EV-to-EBITDA for today is calculated as:
Kyowa Kirin Co's current Enterprise Value is 円1,021,393 Mil.
Kyowa Kirin Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円91,477 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kyowa Kirin Co (TSE:4151) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Kyowa Kirin Co's PE Ratio for today is calculated as:
Kyowa Kirin Co's share price for today is 円2612.50.
Kyowa Kirin Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円107.730.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Kyowa Kirin Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4151 has been successfully added to your 